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Background: The burden of disease from childhood obesity is considerable worldwide, as it is associated with
several co-morbidities, such as dyslipidemia, hypertension, type 2 diabetes (T2DM), orthopedic and psychosocial
problems. We aimed at determining the prevalence of these complications in a population of children and
adolescents with body weight excess.
Methods: This is a cohort study including 774 new patients (1.7 - 17.9 yrs, mean 11.1 ± 3.0) attending a pediatric
obesity care center. We assessed personal and family medical histories, physical examination, systemic blood
pressure, biochemical screening tests.
Results: We found that the great majority of the children suffered from at least one medical complication.
Orthopedic pathologies were the most frequent (54%), followed by metabolic (42%) and cardiovascular disturbances
(31%). However, non-medical conditions related to well-being, such as bullying, psychological complaints, shortness of
breath or abnormal sleeping patterns, were present in the vast majority of the children (79.4%). Family history of
dyslipidemia tends to correlate with the child’s lipids disturbance (p = .053), and ischemic events or T2DM were
correlated with cardiovascular risk factors present in the child (p = .046; p = .038, respectively).
Conclusions: The vast majority of obese children suffer from medical and non-medical co-morbidities which must be
actively screened. A positive family history for cardiovascular diseases or T2DM should be warning signs to perform
further complementary tests. Furthermore, well-being related-complaints should not be underestimated as they were
extremely frequent.
Keywords: Cardiovascular disease, Musculo-skeletal, Metabolism, Co-morbidities, Childhood obesityBackground
Children with body weight excess are an important high
risk group for health complications. This population suf-
fers already at an early age of multiple complications lead-
ing to increased health risks and costs in adult life [1-3].
However, there are disparities in epidemiological data,
depending on where the studies are performed, the se-
lected populations and the clinical settings. Indeed, most* Correspondence: albane.maggio@hcuge.ch
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population, but are likely to be of increasing importance
as even if stabilizing, the prevalence of childhood obesity
in our country is still of 20% [4]. Therefore, it is import-
ant to collect data from a clinical population to evaluate
their prevalence. To our knowledge, no studies have
investigated the concomitant occurrence of medical (car-
diovascular, metabolic, orthopedic) and non-medical com-
plications in a large sample of overweight or obese
children and adolescents. Therefore, we aimed first at de-
termining the prevalence of obesity-related co-morbidities
in a cohort of children with body weight excess con-
sulting in a specialized obesity center and second at com-
paring those complications between overweight, obesel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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numbers of complications increase with weight status.
Methods
Study design and subjects
This was a cohort study including 774 subjects with ex-
cessive body weight (BMI z-score above one SD for age
and gender) [5], aged 1.7 to 17.9 years (mean age 11.1 ±
3.0), attending our Pediatric Obesity Care Center be-
tween January 2008 and August 2012. Our center is the
only one taking care of obese children in our county for
a population of 49’500 children aged between 5 and
16 years old. Data were collected both retrospectively
and prospectively. Children were referred, if they had a
BMI z-score above one SD, by their general practi-
tioners, school nurses or by the Child and Adolescent
Department of the Geneva University Hospitals to follow
a multidisciplinary therapeutic program. The only exclu-
sion criterion was a normal weight (BMI z-score under
one SD).
Once informed, a written consent was obtained from
both parent and child during the prospective phase of
the study. All subjects accepted to participate. The
Mother and Child Ethics Committee of the University
Hospitals of Geneva approved the study.
Measures
Medical history, physical examination and laboratory
tests were used to define medical complications: ortho-
pedic (analyzing 3 different complications); cardiovascu-
lar (analyzing 7 different risk factors) and metabolic
(analyzing 4 different anomalies); as well as non-medical
complications related to well-being (analyzing 4 different
complaints).
Medical history
At the first visit, a semi-structured interview (see Additional
file 1) following an established protocol was taken by a
pediatrician and used similarly for all subjects, to obtain a
detailed personal medical history. We assessed the fre-
quent complaints reported in childhood obesity that are
known to have an impact on their well-being, such as
bullying, psychological complaints (depressiveness/poor
emotional feelings, preoccupation with physical appear-
ance and self-esteem), shortness of breath or abnormal
sleeping patterns (delayed onset or early or frequent awak-
enings). We had only 6% of missing data.
We also obtained a family medical history through par-
ent report, including parents and grand-parents, searching
for the presence of obesity, type 2 diabetes (T2DM),
dyslipidemia, systemic hypertension and ischemic events,
such as myocardial or cerebral infarctions. The ethnic
background was classified depending on parental origin:
European, Hispanic, Asian, African or Oriental.Physical examination
We measured body weight (kg), height (cm), and waist
circumference (cm). Body mass index (BMI) was calcu-
lated as weight/height squared (kg⋅m−2) and z-scores
were calculated using the World Health Organization
references [5]. Children with a BMI z-score between one
and two, between two and three and above three were
defined as overweight, obese and extremely obese, re-
spectively. During physical examination, we examined all
subjects for acanthosis nigricans, and for signs of ortho-
pedic conditions such as pes planus (the entire internal
plantar arch comes into complete or near-complete con-
tact with the ground), hyperlordosis and genu valgum
(intermalleolar distance ≥ eight cm). We had only 6% of
missing data for the orthopedic examination.
Laboratory
Fasting plasma glucose [mmol⋅l−1], total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), triglycerides
(TG) and alanine aminotransferase (ALAT) levels [U.l−1]
were determined using standard automated techniques
(SYNCHRON LX20®). Low-density lipoprotein cholesterol
(LDL-C) level [U.l−1] was calculated according to the
Friedewald formula [6]. Thyroid-stimulating hormone
(TSH) [mUl.−1] was measured using an automated im-
munoassay analyzer platform and insulin concentration
using radioimmunoassay (Access® ultrasensitive insulin,
Beckman Coulter Ireland Inc.). Insulin resistance was eval-
uated by the homeostasis model (HOMA-IR = fasting insu-
lin [μU⋅ml−1] × fasting glucose [mmol⋅l−1]/22.5) and an
oral glucose tolerance test was performed when needed [7].
Results were considered abnormal if: TC, LDL-C, and
TG levels were > 95th percentile and HDL-C < 5th per-
centile for age and gender according to pediatric guidelines
[8]; ALAT > 40 (U.l−1); TSH: > 4 (mUl.−1) [9]; insulin > 15
(μU⋅ml−1); HOMA-IR > 4 [10]. Impaired fasting glucose
(IFG), impaired glucose tolerance (IGT) or type 2 diabetes
(T2DM) were defined according to the American Diabetes
Association [11].
Laboratory tests were considered in the analysis if per-
formed in a time scale of two months around the first
visit. In average we had 63% of missing data for the
blood analysis.
Blood pressure
Systemic blood pressure was measured on the right arm
after 10 minutes’ rest in the supine position, using a stand-
ard, automated device (Philips SureSigns VS3, Philips
Medical System, Andover, USA). The cuff covered two-
thirds of the length of the upper arm, with the length of
the bladder covering the arm circumference. In case of
values above the 95th percentage for age, gender and
height [12], measurements were taken again 3 times after
2 to 5 minutes and the lowest was recorded. Systolic and
Maggio et al. BMC Pediatrics 2014, 14:232 Page 3 of 9
http://www.biomedcentral.com/1471-2431/14/232diastolic blood pressure z-scores were determined [13],
and hypertension was defined as values above the 95th
percentile for age, gender and height [12]. We had 13% of
missing data.
There was no missing data in 174 patients.
Statistical analysis
Statistical analyses were performed using the SPSS soft-
ware 18.0 (Chicago, IL). Data were presented as mean
and standard deviation (SD) or number and valid per-
centage. Statistical differences between overweight and
obese subjects concerning occurrence of complications,
age, BMI z-score and gender were analyzed using inde-
pendent Student t-test or chi-square test. A multiple lo-
gistic regression model was used to estimate the odd
ratio (OR) to have a selected complication between over-
weight (controls) and obese (cases) children, controlling
for age and gender. Analysis of variance (ANOVA) with
Bonferroni post-hoc test was used to compare the pres-
ence of complications per weight status, age categories
and ethnic groups. We evaluated also the relationship
between complications and BMI z-scores using linear
regression. Pearson coefficient correlation was used to
correlate family medical history and the presence of
complications in the child. Differences were considered
significant if P < 0.05.
Results
Subjects’ characteristics (n = 774)
There were 399 (52%) girls, mean age was 11.1 ± 3.0 years
and mean BMI z-score was 2.7 ± 0.9. Our cohort was
composed of 15.4% overweight subjects (n = 119/774;
mean age: 12.1 ± 2.6 yrs), 56.3% obese (n = 436; mean
age: 11.4 ± 2.6 yrs) and 28.3% extremely obese children
(n = 219; mean age: 9.8 ± 3.6 yrs, representing 33.4% of
the obese group).
Ethnic background showed that 46.8% came from
European countries, 15.0% Hispanic, 16.9% African, 7.2%
Oriental and 3.4% Asian countries. Data were missing
for 10.7% (n = 83/774).
Table 1 presents the main obesity-related complications
according to weight status, as well as the risks (OR) of
these complications for obese or extremely obese children
to present such conditions compared to overweight sub-
jects, when controlling for age and gender.
Orthopedic complications
Orthopedic conditions were present in 53.6% of subjects
and their prevalence increased with weight status
(ANOVA with post-hoc test: p < .001 between each
groups). Genu valgum was the most commonly found
complication (33%, n = 258/773), followed by pes planus
(28%, n = 201/727) and hyperlordosis (25%, n = 185/727).Cardiovascular risk factors
Cardiovascular risk factors, such as hypertension (HTN)
and lipid anomalies, were present in 31.2% of subjects,
and their global prevalence was significantly increased in
the obese and extremely obese groups compared to the
overweight subjects (p < .01). Systolic and diastolic HTN
were present in 17% (n = 116/675) and 6% (n = 41/672)
of screened children, respectively. They were simultan-
eously present in 4% of subjects (n = 25/672). Blood
pressure z-scores were highly related to the BMI z-score
(systolic: t = 5.0 and diastolic: t = 4.0; p < .001 for both).
In fact, the risk to develop systolic HTN increased with
the weight status, as when compared to overweight sub-
jects, the risk increased of 2.5 for obese and almost five-
fold for extremely obese children (Table 1).
Forty percent of children had dyslipidemia. Low HDL-C
was the most frequent disturbance (23%, n = 65/287),
followed by high TC (19%, n = 54/290) and LDL-C (13%,
n = 36/285). High TG was very rare with only two obese
and one extremely obese subjects being above the normal
range. BMI z-score was higher in subjects with low
HDL-C (3.2 ± 0.8 vs. 2.8 ± 0.8 U.l−1, p = .001) and TC and
LDL-C levels were more frequently abnormal in over-
weight compared to obese children (Table 1).
Metabolic complications
Metabolic complications, such as abnormal glucose, insu-
lin, TSH or ALAT levels, were present in 42.1% of sub-
jects, without difference among weight status (Table 1).
Glucose metabolism was normal in almost 90% of chil-
dren. After oral glucose tolerance tests, two of them (1%)
were diagnosed with T2DM (one girl aged 13 yrs with a
BMI z-score of 2.3 and a boy aged 16 yrs with a BMI z-
score of 3.6), 4% of them had impaired glucose tolerance
(n = 12/296; mean age: 13.3 ± 2.2 yrs; mean BMI z-score:
2.9 ± 0.8) and 6% of them had impaired fasting glucose
(n = 18/296; mean age: 12.1 ± 3.0 yrs; mean BMI z-score:
2.6 ± 0.6). The rate of hyperinsulinemia or insulin resist-
ance was high (33%, n = 86/259), but was independent of
the weight status when controlled for age and gender.
Furthermore, almost 20% (n = 144/727) presented an
acanthosis nigricans on clinical examinations, which was
positively correlated with insulin resistance for 44% (r =
0.132, p = .032), with a tendency for hyperinsulinemia in
38% of cases (r = 0.116, p = .059).
We also assessed TSH and ALAT concentrations in
some children. We found elevated TSH and ALAT levels
in 8% (n = 21/264) and 12% (n = 25/204) of them, respect-
ively. There was no difference between weight status
(Table 1); however, ALAT increased significantly with
BMI z-score (t = 2.8, p = .006) and insulin concentration
(t = 5.0, p < .001). ALAT was also more frequently abnor-
mal in boys (21% of boys vs. 5% of girls; p = .001). Only
one child and two adolescents had ALAT concentrations
Table 1 Selected obesity-related complications according to weight status
Overweight Obese Extreme obese
N 119 436 219
Age (years) 12.1 ± 2.6 11.4 ± 2.6 9.8 ± 3.6
Gender (% girls) 74 53 36
BMI z-score 1.7 ± 0.24 2.5 ± 0.3 3.8 ± 0.8
WC (cm) 78.3 ± 9.8 84.0 ± 11.2 87.4 ± 15.7
n; (% within obesity status) OR (95% CI) OR (95% CI)
Obese Extreme Obese
Orthopedic complications:
Genu valgum 15/119 (12.6) 145/436 (33.3) 98/218 (45.0) 3.4 (1.9 – 6.2)*** 4.7 (2.5 – 8.8)***
Pes planus 18/104 (17.3) 104/416 (25.0) 79/207 (38.2) 1.4 (0.8 – 2.5) 2.1 (1.1 – 3.9)*
Hyperlordosis 14/104 (13.5) 101/416 (24.3) 70/207 (33.8) 1.9 (1.0 – 3.6)* 2.3 (1.1 – 4.5)*
Cardiovascular risk factors:
Systolic HTN 8/99 (8.1) 63/388 (16.2) 45/188 (23.9) 2.5 (1.2 – 5.5)* 4.8 (2.1 – 11.1)***
Diastolic HTN 2/99 (2) 23/387 (5.9) 16/186 (8.6) 3.1 (0.7 – 13.4) 3.9 (0.8 – 18.7)
High TC 11/31 (35.5) 26/158 (16.5) 17/101 (16.8) 0.27 (0.1 – 0.7)** 0.21 (0.1 – 0.6)**
High LDL-C 7/30 (23.3) 15/156 (9.6) 14/99 (14.1) 0.29 (0.1 – 0.8)* 0.37 (0.1 – 1.2)
Low HDL-C 3/30 (10) 31/157 (19.7) 31/100 (31.0) 2.3 (0.7 – 8.3) 4.4 (1.2 – 16.3)*
Metabolic complications:
IFG/IGT/T2DM 5/31 (16.1) 19/162 (11.7) 8/103 (7.8) 0.83 (0.3 – 2.6) 0.62 (0.2 – 2.3)
Hyperinsulinemia or IR 11/27 (40.7) 40/141 (28.4) 35/91 (38.5) 0.81 (0.3 – 2.0) 2.2 (0.8 – 6.1)
High ALAT 2/19 (10.5) 8/108 (7.4) 15/77 (19.5) 0.48 (0.1 – 2.9) 1.6 (0.3 – 9.8)
High TSH 2/29 (6.9) 10/147 (6.8) 9/88 (10.2) 0.95 (0.2 – 4.7) 1.6 (0.3 – 8.7)
Non-medical complications:
Shortness of breath 17/104 (16.3) 119/417 (28.5) 95/207 (45.9) 1.86 (1.1 – 3.3)** 3.15 (1.7 – 5.9)***
Sleep disturbance 10/104 (9.6) 45/416 (10.8) 38/207 (18.4) 1.06 (0.5 – 2.2) 1.62 (0.7 – 3.6)
Bullying 30/104 (28.8) 154/417 (36.9) 78/207 (37.7) 1.50 (0.9 – 2.4) 1.58 (0.9 – 2.7)
Psychological complaints 67/105 (63.8) 290/417 (69.5) 122/207 (58.9) 1.54 (0.9 – 2.5) 1.35 (0.8 – 2.3)
Data are express as mean and standard deviation.
For limits of pathological values, refer to the Methods section.
Odd ratio (OR) controlled for age and gender; controls being the overweight group.
*p < .05, **p < .01 and ***p < .001.
WC: waist circumference; HTN: hypertension; TC: total cholesterol; IFG: impaired fasting glucose; IGT: impaired glucose tolerance; T2DM: type 2 diabetes; IR: insulin resistance.
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tests, allowing other liver diseases to be ruled out. Those
three subjects showed improved ALAT concentrations at
follow-up. No subjects were diagnosed with liver diseases
during their follow-up.
Waist circumference was a good indicator of metabolic
disturbance, as it was significantly higher in children with
abnormal glucose metabolism, hyperinsulinemia or high
HOMA-IR (waist circumference with normal HOMA-IR:
81.8 ± 10.8 vs. with abnormal HOMA-IR: 91.5 ± 12.3;
p < .001), even after adjusting the age.
Non-medical complications
Non-medical complications related to well-being were
assessed using a semi-structured interview during the clin-
ical evaluation and concerned 79.6% of them. Shortness ofbreath during physical activities was reported by 32%
(n = 231/728) of the subjects, especially in obese and ex-
tremely obese children (Table 1), and poor sleep quality
was observed for 13% (n = 93/727) of them. Almost forty
percent of them (n = 262/728) were victims of bullying at
school or at home, and for 66% (n = 479/729) the physical
appearance was a major issue, independently of their
weight status or BMI z-score.
Age role
Children were also classified according to their age: less
than 8 years old (n = 117/774, 15.1%), 8 to 12 (n = 349,
45.1%), 12 to 14 (n = 164, 21.2%) and more than 14 years
old (n = 144, 18%).
The percentage of medical and non-medical complica-
tions by age category is shown in Figure 1. The frequency
Figure 1 Prevalence of medical and non-medical complications by age category.
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nus and genu valgum) decreased progressively with age,
being more frequent in children younger than 8 years old
compared to the other age groups (p < .001 for all).
The rate of systolic and diastolic HTN were also
higher in younger children (<8 yrs) (p < .05 for all), but
there was no difference in lipids anomalies among age
groups.
On the contrary, glucose, insulin and ALAT anomalies
were more frequent in adolescents older than 14 years
compared to the other age groups (p < .05 for all).
Poor sleep quality, as well as shortness of breath was
more frequent in children younger than 12 years, but
psychological complaints were less frequent in the youn-
ger ones (<8 years) (p < .05). There was no difference
concerning bullying among age categories.
Role of ethnicity
Ethnic differences were found only for metabolic com-
plications (p = .002), with a lower prevalence in African
compared to European (African: n = 12/55, 9.1% vs.
European: n = 69/150, 19.1%; p = .036) or Asian subjects
(Asian: n = 7/12, 26.9%; p = .003). Those differences con-
cerned the insulin anomalies in relation to European
(African: n = 6/51, 4.6% vs. European: n = 47/131, 13%;
p = 0.013) and ALAT anomalies in relation to Asian
(African: n = 0/41 vs. Asian: n = 5/11, 19.2%, p < .001). In
fact, ALAT levels were abnormal more frequently in Asian
compared to the other ethnic groups (European: n = 10/
98, 2.8%, p = .003; Hispanic: n = 4/30, 3.4%, p = .026;
Oriental: n = 2/15, 3.6%, p = .073).
Family history
Family medical history revealed many complications in
parents and grand-parents, as at least one of them
suffered from: systemic HTN in 42% (n = 299/719),dyslipidemia in 35% (n = 250/719), T2DM in 13% (n =
73/560) and ischemic event (myocardial or cerebral) in
16% of cases (n = 120/771). Family dyslipidemia tended
to be correlated to the number of lipid abnormalities
found in the child (r = 0.115, p = .053), and history of is-
chemic event or T2DM were correlated with the total
number of cardiovascular risk factors in the child (ische-
mic event: r = 0.074, p = .046; T2DM: r = 0.09, p = .038).Summary of complications in a sub-group of subjects
As to minimize the potential bias due to missing data,
we calculated the prevalence of the complications, as
well as their correlation with BMI z-score, in a sub-
group of subjects without missing data (n = 174). Com-
pared to the entire cohort, the gender repartition (52.9
vs. 52% of girls), as well as mean ages and BMI z-scores
(mean ages: 10.6 ± 2.9 vs. 11.1 ± 3.0 yrs; mean BMI z-
scores: 2.9 ± 0.8 vs. 2.7 ± 0.9) were quite similar. There
was slightly less overweight (10.3 vs. 15.4%) and more
extremely obese subjects (35.1 vs. 28.3%) in this sub-
group. The mean number of medical complications was
2.5 ± 1.6 (range: 0 to 8), and 4.3 ± 2.1 when adding non-
medical ones. The repartition of the subjects according
to the number of complications they present is displayed
in Table 2. Almost 90% of the children are affected by at
least one medical co-morbidity, without gender difference.Discussion
A careful evaluation of subjects with body weight excess,
presented to a pediatric obesity clinic, revealed that both
medical and non-medical complications affecting psy-
chological well being are very frequent. Some, but not
all of them increased with weight status. We categorized
those complications as follows: orthopedic, cardiovascu-
lar, metabolic and non-medical.
Table 2 Prevalence of medical and non-medical complications and their correlation with BMI z-score, in a sub-group of
174 subjects
Prevalence of complications in % Number of complications Corr coeff with BMI z-score
N= 0 ≥1 1 2 ≥3
Orthopedic 32.2 67.8 32.2 28.7 6.9 0.129
Cardiovascular 48.3 51.7 28.2 15.5 8.0 0.152*
Metabolic 59.8 40.2 25.9 10.9 3.4 0.090
Subtotal 10.4 89.6 19.5 23.0 47.1 0.206**
Non-medical 14.4 85.6 26.4 29.9 29.3 0.076
Total 2.3 97.7 5.2 13.8 78.7 0.200**
Corr coeff: correlation coefficient using Pearson correlation between BMI z-score and each complication.
*p < .05, **p < .01.
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dren, but few of them investigated the prevalence of
common orthopedic conditions [14-16], representing the
second most frequent complication, after the psycho-
logical one, found in our cohort. More than 50% of sub-
jects have at least one of those conditions, similarly to
previous results found for a similar population [16]. This
is an important finding as physical activity may be lim-
ited due to pain or mechanical limitations [15,17], and
therefore may possibly impact on treatment’ success. Flat
foot incidence in obese children ranges from 5 to 28%,
mirroring our results [18-20]. Prevalence of musculo-
skeletal and lower limb valgus alignment complications
vary depending on the studies: a previous large cohort
study has shown that their prevalence is greater in over-
weight than in normal weight children (complaints:
18.3% vs. 4.8%; valgus: 11% vs. 3.2%) [15]. Two other small
studies reported a higher rate of genu valgum in obese
children (rate 50 and 55%) which confirm the difference
between normal and overweight subjects [14,16]. Hyper-
lordosis has been less well studied, but one report focusing
on obese children showed a similar prevalence [16]. Inter-
estingly, in our cohort, the prevalence of those complica-
tions seems to be more frequent in younger children, but
it may simply reflect the fact that they were also the most
obese. Indeed, after age adjustment, those conditions in-
creased with weight status.
Cardiovascular diseases risk factors are widely studied
in this population, as their numbers are related to the
severity of atherosclerotic changes [21]. In our cohort
study, we found that 23% of subjects had either systolic
or diastolic hypertension, confirming previous studies
(15 to 52%) [22-25]. The magnitudes of blood pressure
z-scores were proportional to the degree of adiposity, as
already documented [22,24,26], and the risk to present
systolic HTN in the obese and extremely obese groups
were increased by 2.5 and almost five fold, respectively,
compared to the overweight group. HTN was not cor-
related to family hypertension. Furthermore 40% of
children had dyslipidemia; however abnormal TG level,often described to be elevated in obese subjects [26],
was very rare in our cohort without any clear explan-
ation. The prevalence of abnormal lipids in the obese
groups was similar than in the literature [26]. However
they were lower than the one found in overweight sub-
jects, contradicting preceding studies [22,27]. However,
it is difficult to compare those two groups, as only
around 25% of overweight subjects were screened,
against 40% of the obese and extremely obese children.
This low rate was due to the fact that some of them had
already been screened before or missed the blood test
appointment. Furthermore, when an overweight child
had no family history of cardiovascular disease, we were
less prone to perform such exam at the beginning of the
follow-up. On the contrary to HTN and orthopedic
complications, lipids disturbances were not dependent of
BMI, except for HDL-C, but were rather correlated to
positive family history of dyslipidemia, corroborating the
genetic predisposition put forward by others [28-30]. In
our study, the total number of CVD risk factors per sub-
jects was correlated to family history of ischemic events,
also suggesting the genetic component.
The increased prevalence of abnormal glucose metab-
olism or type 2 diabetes is debated in youth [31-34]. Its
detection is widely performed in clinical settings; how-
ever, our study revealed that only 10% of the tested
children had glucose metabolism disturbances, which
confirms results found in previous publications [31,35].
Insulin secretion anomalies were far more frequent but
interestingly were not related to the severity of obesity
but rather to the subject’s age, which isn’t in total ac-
cordance with published data [10,36]. Children with
African origin had less insulin anomalies than those
from European countries, corroborating epidemiological
data showing a low risk of diabetes in African subjects
[37], contrary to African-American [38,39]. It is interest-
ing to note that acanthosis nigricans and insulin resist-
ance were concomitant in only 45% of children. As
already known [40], waist circumference was a good in-
dicator of insulin disturbance.
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was present in only 8% of children in our cohort. Others
showed that elevated TSH level was found in 10 to 23%
of obese children, as a consequence rather than a cause
of obesity [41]. Since weight loss, as well as natural his-
tory, are associated with normalization of TSH [42-44],
the question of the necessity of such screening must be
raised, especially if clinical hypothyroidism is not suspect
during the clinical examination.
Increased hepatic enzymes, such as ALAT, suggest a
non-alcoholic fatty liver disease (NAFLD) also in chil-
dren [45]. In our study, 7% of obese and 20% of ex-
tremely obese subjects had an increased level of ALAT,
which stands between 6 to 25% found in the literature
studying similar populations [46,47]. In our cohort, the
prevalence was higher in Asian subjects but this result
must be taken with caution as we had only 11 Asian
subjects. Indeed, the prevalence doesn’t seem to differ
according to ethnic background [48]. This condition is
important to detect, as it can lead to hepatic fibrosis and
cirrhosis [49]. Such finding may be a strong motivator
for the child and his family to change behaviors, as no
treatment, other than weight management, has proven
to be effective.
Finally, almost 80% of children complained about non-
medical conditions affecting their well-being and quality
of life, and it is by far the most frequent complication
found in this population. Physical appearance and well-
being are very important during growth and are often
the main sources of motivation to seek medical atten-
tion. Interestingly, these complaints were independent of
the real weight excess and affected both boys and girls.
A recent review about quality of life revealed that obese
children have impaired physical, social and emotional
functioning compared to their lean counterparts [50].
These may lead to psychological distress, and should be
screened and addressed, as they may impact treatment
success and psychosocial development.
The strengths of this study were the wide age range
and the large percentage of children studied in the
unique centre dealing with obese children in the area.
However, we can’t exclude a selection bias, as the chil-
dren attending our care center may be the most affected
by their condition, making generalization difficult.
The limitations encountered with this cohort were
first, that blood tests were probably performed more
early in overweight subjects with a higher risk of co-
morbidities, which may falsely increase the prevalence of
complications in this group. Secondly, as the pubertal
status was missing in the majority of the subjects, we
couldn’t adapt the cut-off point for insulin level. We
choose the limit at 15 μU/ml, corresponding to pubertal
stage I, as the majority of the subjects for whom we had
the data were at this stage. Third, we didn’t evaluate thequality of life using a validated questionnaire, due to set-
ting limitation. And finally, missing data may introduce
a bias in the relative prevalence of each complication in
our population. To address this question, we selected a
sub-group of children for whom data were complete. Re-
sults showed that non-medical complications were the
most frequent, followed by orthopedic, cardiovascular
and finally metabolic. In total, almost all the children
suffered of at least one of those co-morbidities.
Conclusions
As a conclusion, a large majority of children and adoles-
cents with body weight excess seeking medical advice
are suffering from a variety of complications. Psycho-
social difficulties should not be underestimated as the
related complaints were the most frequently reported
and were not related to the magnitude of the obesity. All
the co-morbidities should be actively screened as they
are known to have an impact on future health. Pediatri-
cians and general practitioners have a major role in this
screening as they can improve quality of care by treating
these complications as soon as possible. Such findings can
also be a potential source of motivation to stabilized or re-
duce weight gain. Finally, the biggest challenge would be
the prevention of excessive weight gain in the general
population, as the prevalence of the majority of the co-
morbidities was directly dependant on the weight status.
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